This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Packaging Remove Research Laboratories Related Topics
Vaccines More Related Topics >
article thumbnail

Merck to support development of Orna’s circular RNA (oRNA) therapies

European Pharmaceutical Review

AUGUST 18, 2022

Newly synthesised oRNA molecules are more compactly packaged into custom LNPs, which Orna has engineered to target key tissues in the body. Orna’s proprietary oRNA technology creates circular RNAs from linear RNAs by self-circularisation. We look forward to working with the talented scientific and technical teams at Orna.”

Vaccines 87
Vaccines Research Laboratories Packaging 87
article thumbnail

Merck and Orna partner for RNA technology-based vaccines and therapies

Pharmaceutical Technology

AUGUST 17, 2022

These molecules synthesised newly are packaged densely into custom lipid nanoparticles (LNPs), which Orna has made to act on the body’s crucial tissues. By self-circularisation, Orna’s oRNA technology makes circular ribonucleic acids (oRNAs) from linear RNAs.

Vaccines 59
Vaccines Research Laboratories Packaging 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024